These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36935271)
1. Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence. Bandarian F; Qorbani M; Aalaa M; Peimani M; Larijani B; Nasli-Esfahani E Prim Care Diabetes; 2023 Jun; 17(3):238-241. PubMed ID: 36935271 [TBL] [Abstract][Full Text] [Related]
2. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Karatas S; Yesim T; Beysel S Prim Care Diabetes; 2021 Jun; 15(3):424-427. PubMed ID: 33441263 [TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499 [TBL] [Abstract][Full Text] [Related]
4. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes. Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900 [TBL] [Abstract][Full Text] [Related]
5. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348 [TBL] [Abstract][Full Text] [Related]
6. The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Ojo O; Wang XH; Ojo OO; Orjih E; Pavithran N; Adegboye ARA; Feng QQ; McCrone P Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162117 [TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Wafa IA; Pratama NR; Sofia NF; Anastasia ES; Konstantin T; Wijaya MA; Wiyono MR; Djuari L; Novida H Diabetes Metab J; 2022 Mar; 46(2):260-272. PubMed ID: 35255551 [TBL] [Abstract][Full Text] [Related]
8. The impact of a telehealth intervention on the metabolic profile of diabetes mellitus patients during the COVID-19 pandemic - A randomized clinical trial. Franco DW; Alessi J; de Carvalho TR; Kobe GL; Oliveira GB; Knijnik CP; Amaral B; Becker AS; Schaan BD; Telo GH Prim Care Diabetes; 2022 Dec; 16(6):745-752. PubMed ID: 36266163 [TBL] [Abstract][Full Text] [Related]
9. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes. Tannus LRM; Zapelini RM; Cabizuca CA; Abi-Abib RC; Matheus ASM; Calassara PC; Pozzan R; Cobas RA Endocrine; 2022 Sep; 77(3):455-460. PubMed ID: 35838896 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020. Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352 [TBL] [Abstract][Full Text] [Related]
11. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes. Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic Control in Adults with Type 1 and Type 2 Diabetes. Hartmann B; Tittel SR; Femerling M; Pfeifer M; Meyhöfer S; Lange K; Milek S; Stemler L; Best F; Holl RW Exp Clin Endocrinol Diabetes; 2022 Sep; 130(9):621-626. PubMed ID: 35181878 [TBL] [Abstract][Full Text] [Related]
13. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602 [TBL] [Abstract][Full Text] [Related]
14. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications. M Tourkmani A; J ALHarbi T; Rsheed AMB; Alrasheedy AA; ALMadani W; ALJuraisi F; AlOtaibi AF; AlHarbi M; AlAbood AF; Alshaikh AA J Telemed Telecare; 2023 Jun; 29(5):390-398. PubMed ID: 33525952 [TBL] [Abstract][Full Text] [Related]
15. Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic. Ali N; El Hamdaoui S; Nefs G; Tack CJ; De Galan BE BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35606020 [TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes. Duarte V; Mota B; Ferreira S; Costa C; Correia CC Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population. Farhane H; Motrane M; Anaibar FE; Motrane A; Abeid SN; Harich N Prim Care Diabetes; 2021 Oct; 15(5):772-777. PubMed ID: 34172426 [TBL] [Abstract][Full Text] [Related]
18. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai. Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807 [TBL] [Abstract][Full Text] [Related]
19. The impact of a prolonged lockdown and utilization of diabetes telemedicine on cardiometabolic health in people with diabetes during the COVID-19 outbreak in Saudi Arabia. Al-Sofiani ME; AlMesned RK; Bafadel MS; Alguwaihes AM; Alfadda AA Prim Care Diabetes; 2022 Oct; 16(5):644-649. PubMed ID: 35773134 [TBL] [Abstract][Full Text] [Related]
20. Weight gain in type 1 diabetes during the SARS-CoV-2 pandemic. Does lockdown affect the metabolic control of pediatric patients? Zubkiewicz-Kucharska A; Wikiera B; Noczyńska A Front Endocrinol (Lausanne); 2022; 13():991269. PubMed ID: 36313778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]